XKRX:082270 (Korea (the Republic of))
Â
Ordinary Shares
â‚©
11690.00
(+0.17%)
May 17
Current and historical daily PE Ratio for GemVax & KAEL Co Ltd (
XKRX:082270
) from 2005 to May 17 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. GemVax & KAEL stock (XKRX:082270) PE ratio as of May 17 2024 is 0.
More Details
GemVax & KAEL Co Ltd (XKRX:082270) PE Ratio (TTM) Chart
GemVax & KAEL Co Ltd (XKRX:082270) PE Ratio (TTM) Historical Data
View and export this data going back to 2005. Start your Free Trial
Total 1255
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| GemVax & KAEL PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-05-17 | At Loss | 2024-03-12 | At Loss |
| 2024-05-17 | At Loss | 2024-03-11 | At Loss |
| 2024-05-16 | At Loss | 2024-03-08 | At Loss |
| 2024-05-14 | At Loss | 2024-03-07 | At Loss |
| 2024-05-13 | At Loss | 2024-03-06 | At Loss |
| 2024-05-10 | At Loss | 2024-03-05 | At Loss |
| 2024-05-09 | At Loss | 2024-03-04 | At Loss |
| 2024-05-08 | At Loss | 2024-02-29 | At Loss |
| 2024-05-07 | At Loss | 2024-02-28 | At Loss |
| 2024-05-03 | At Loss | 2024-02-27 | At Loss |
| 2024-05-02 | At Loss | 2024-02-26 | At Loss |
| 2024-04-30 | At Loss | 2024-02-23 | At Loss |
| 2024-04-29 | At Loss | 2024-02-22 | At Loss |
| 2024-04-26 | At Loss | 2024-02-21 | At Loss |
| 2024-04-25 | At Loss | 2024-02-20 | At Loss |
| 2024-04-24 | At Loss | 2024-02-19 | At Loss |
| 2024-04-23 | At Loss | 2024-02-16 | At Loss |
| 2024-04-22 | At Loss | 2024-02-15 | At Loss |
| 2024-04-19 | At Loss | 2024-02-14 | At Loss |
| 2024-04-18 | At Loss | 2024-02-13 | At Loss |
| 2024-04-17 | At Loss | 2024-02-08 | At Loss |
| 2024-04-16 | At Loss | 2024-02-07 | At Loss |
| 2024-04-15 | At Loss | 2024-02-06 | At Loss |
| 2024-04-12 | At Loss | 2024-02-05 | At Loss |
| 2024-04-11 | At Loss | 2024-02-02 | At Loss |
| 2024-04-09 | At Loss | 2024-02-01 | At Loss |
| 2024-04-08 | At Loss | 2024-01-31 | At Loss |
| 2024-04-05 | At Loss | 2024-01-30 | At Loss |
| 2024-04-04 | At Loss | 2024-01-29 | At Loss |
| 2024-04-03 | At Loss | 2024-01-26 | At Loss |
| 2024-04-02 | At Loss | 2024-01-25 | At Loss |
| 2024-04-01 | At Loss | 2024-01-24 | At Loss |
| 2024-03-29 | At Loss | 2024-01-23 | At Loss |
| 2024-03-28 | At Loss | 2024-01-22 | At Loss |
| 2024-03-27 | At Loss | 2024-01-19 | At Loss |
| 2024-03-26 | At Loss | 2024-01-18 | At Loss |
| 2024-03-25 | At Loss | 2024-01-17 | At Loss |
| 2024-03-22 | At Loss | 2024-01-16 | At Loss |
| 2024-03-21 | At Loss | 2024-01-15 | At Loss |
| 2024-03-20 | At Loss | 2024-01-12 | At Loss |
| 2024-03-19 | At Loss | 2024-01-11 | At Loss |
| 2024-03-18 | At Loss | 2024-01-10 | At Loss |
| 2024-03-15 | At Loss | 2024-01-09 | At Loss |
| 2024-03-14 | At Loss | 2024-01-08 | At Loss |
| 2024-03-13 | At Loss | 2024-01-05 | At Loss |
GemVax & KAEL Co Ltd (XKRX:082270) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
GemVax & KAEL Co Ltd
NAICS : 334413
SIC : 3674
ISIN : KR7082270000
Share Class Description:
XKRX:082270: Ordinary SharesCompare
Compare
Traded in other countries / regions
082270.Korea IPO Date
2005-06-24Description
GemVax & KAEL Co Ltd is primarily engaged in manufacturing and commercializing of coating resin and filters for semiconductors and panel display production. It offers chemical air filter, scrubber resin, and devices for preventing environmental contamination and eliminating harmful gas, for semiconductor and display industry. Its other business operations include research and development of anti-cancer immunotherapeutic and peptide drugs. The company organizes its business operations into three distinct segments: Environmental Pollution Control Business, IT Business, Bio-business. The company's product portfolio consists fundamental products, semiconductor, and display, equipment and system, fire evacuation mask 5aver.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers